CVS Health plans split between pharmacy and insurance businesses
CVS Health plans to split into separate pharmacy and insurance businesses, according to Investing.com. The separation would divide a company that generated $402.1 billion in fiscal 2025 revenue across two distinct operating models.
STOCK PHOTO · LEE STARRYThe story
The planned transaction would separate CVS Health’s pharmacy business from its insurance operations, creating two standalone companies. Investing.com reported the decision on Nov. 4, 2026, but the terms, structure and timetable were not specified.
CVS’s fiscal 2025 results provide the latest company-level scale: revenue was $402.1 billion, up 7.8% year over year, while net margin was 0.4% and diluted EPS was $1.39. The proposed split would therefore reorganize a large, low-margin enterprise rather than add a new business line.
The pharmacy business and insurance operations would have different revenue sources, costs and regulatory exposures once separated. Pharmacy activity is tied to dispensing and retail operations, while insurance depends on premiums, medical costs and government-program economics; the reporting establishes the intended separation but not how assets, liabilities or management would be allocated.
Key open points are the transaction structure, tax treatment, debt allocation, leadership, regulatory approvals and timing. Those details would determine how much of CVS’s existing scale and cost base each company retains.
Our read · Wed, Nov 4
CVS Health plans to separate its pharmacy business from its insurance operations.
Why. The split could make CVS’s pharmacy and insurance economics easier to assess, but the trade setup depends on details that determine where the company’s debt, costs and regulatory obligations land. CVS’s fiscal 2025 profile—$402.1 billion of revenue, 0.4% net margin and $1.39 diluted EPS—leaves substantial execution and allocation questions for the separation to resolve.
Both cases
What could change this view: The read fails if the separation is delayed, regulatory or tax costs rise, or debt and overhead allocations leave either standalone business with weaker economics.
Who reported it · 4
Keep reading
More on CVS
CVS warns medical-cost growth remains at high trend; UnitedHealth, Oscar shares fallHealth insurers withdrawing Medicare Advantage plans, affecting seniors in rural marketsLatest on the Wire
SMCI files 10-Q — Quarterly Report: 10-QUS adds 165,000 jobs in October as wages rise and unemployment fallsTrump weighs renewed Iran strikes as negotiators review a new proposalBitcoin holds $76,000 as Nasdaq futures rebound 1.5% before jobs dataModerna swings to profit as cancer-vaccine momentum gathers paceContinue on the Wire →Latest on the Wire
Moderna swings to profit as cancer-vaccine momentum gathers paceFed holds rates as stable labor market keeps December hike on trackFormer BOJ economist sees December hike and 2% terminal rateUS job growth expected to pick up in October, with moderation in wage gainsContinue on the Wire →Top this week
Democrats sweep Congress, setting Trump up for legislative gridlockFutures rebound after blue sweep as dollar slides and gold tops $4,000Bitcoin plunges as AI chip selling drags Nasdaq down more than 2%Trump’s Republican Party faces a midterm verdict from US voters todayBitcoin faces renewed pressure as Binance hack intensifies market fearAbout this report
Reported by Investing.com as CVS Health to split in two, separating pharmacy business from insurance
, . Who answers for this
4 reports from 4 publishers in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
